254 related articles for article (PubMed ID: 1959476)
1. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
Ginsberg HN
Diabetes Care; 1991 Sep; 14(9):839-55. PubMed ID: 1959476
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
Laakso M; Pyörälä K
Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
[TBL] [Abstract][Full Text] [Related]
3. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
5. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
Circulation; 1990 Jul; 82(1):27-36. PubMed ID: 2194696
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
[TBL] [Abstract][Full Text] [Related]
7. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesis.
Nordestgaard BG; Zilversmit DB
Atherosclerosis; 1988 Jul; 72(1):37-47. PubMed ID: 3063265
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of hyperlipidemia in diabetes mellitus.
Abbate SL; Brunzell JD
J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S1-7. PubMed ID: 1710739
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes.
Joven J; Vilella E; Costa B; Turner PR; Richart C; Masana L
Clin Chem; 1989 May; 35(5):813-6. PubMed ID: 2720975
[TBL] [Abstract][Full Text] [Related]
11. Effect of fish oil concentrate on lipoprotein composition in NIDDM.
Schectman G; Kaul S; Kissebah AH
Diabetes; 1988 Nov; 37(11):1567-73. PubMed ID: 3181646
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Taskinen MR; Packard CJ; Shepherd J
Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
[TBL] [Abstract][Full Text] [Related]
13. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
14. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
15. Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.
Bagdade JD; Subbaiah PV
Diabetes; 1989 Oct; 38(10):1226-30. PubMed ID: 2507376
[TBL] [Abstract][Full Text] [Related]
16. Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta).
Hannah JS; Verdery RB; Bodkin NL; Hansen BC; Le NA; Howard BV
J Clin Endocrinol Metab; 1991 May; 72(5):1067-72. PubMed ID: 2022707
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.
Falko JM; Parr JH; Simpson RN; Wynn V
Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM.
Bhatnagar D; Durrington PN; Kumar S; Mackness MI; Dean J; Boulton AJ
Diabetes; 1995 Apr; 44(4):460-5. PubMed ID: 7698516
[TBL] [Abstract][Full Text] [Related]
19. Dyslipoproteinaemia in manifest diabetes.
Manzato E; Crepaldi G
J Intern Med Suppl; 1994; 736():27-31. PubMed ID: 7986305
[TBL] [Abstract][Full Text] [Related]
20. [Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment].
Keller U; Golay A; Pometta D
Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1199-204. PubMed ID: 2237046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
